Antonella Delmestri
PhD
Lead Health Data Scientist
- Alan Turing Alumnus
- EMA-led DARWIN EU® initiative PI data partner
- EHDEN UK data science technical lead
- OHDSI OMOP common data model specialist
- CPRD fob holder for NDORMS
I lead a Data Science group, responsible for the modelling and standardisation of real-world data (RWD) routinely collected by GPs, hospitals and registries, and used in observational research to produce clinical evidence. I am a collaborator of EMA-led DARWIN® EU initiative, EHDEN, OHDSI, and an expert in the OMOP common data model. I am an Alan Turing Alumnus and I serve as member of the Turing Research Ethics (TREx) panel.
My research is focussed on:
- assessment, evaluation and curation of RWD
- impact of RWD quality on medical research output
- data modelling and data standardisation of RWD
- measures of similarity/distance between RWD and their standardised versions
- measurement and enhancement of algorithmic complexity in the context of RWD engineering
- research ethics, research quality, reproducibility, consistency and transparency
BIOGRAPHY
I graduated in Computer Science at the University of Udine and completed my PhD in Information and Communication Technologies at the University of Trento (Italy). I have worked for several years for companies developing firmware and software for electronic devices.
In 2006 I moved to the U.K. to join the Clinical Trial Service Unit (CTSU) at Oxford University. In 2013 I joined NDORMS to work in observational research. In 2018 I joined the European Health Data and Evidence Network (EHDEN) collaboration and in 2019 I started leading the OHDSI UK Data Science technical activities. Between 2021-24 I was a Fellow at the Alan Turing Institute. Since 2022 I am a PI Data Partner in the EMA-led DARWIN® EU initiative.
Recent publications
CohortCharacteristics: an R package for population characterisation in observational studies using the OMOP common data model.
Journal article
Du M. et al, (2026), Eur J Epidemiol
Comorbidities, medication use, and overall survival in eight cancers: a multinational cohort study of 1.7 million patients across Europe.
Journal article
López-Sánchez I. et al, (2026), Lancet Reg Health Eur, 63
Secular trends of incidence and prevalence of Parkinsonism subtypes: a cohort study in the United Kingdom
Journal article
Chen X. et al, (2026), European Journal of Public Health, 36
Validating primary and secondary healthcare resource use and costs estimates in OMOP-mapped vs source CPRD-HES data in the UK
Conference paper
Fabiano G. et al, (2026), Value in Health
Characteristics, treatment and survival of patients with chondrosarcoma in five European countries: a DARWIN EU® cohort study.
Journal article
Barchuk A. et al, (2026), Acta Oncol, 65, 193 - 200
Implementation of OMOP and ConcePTION Common Data Models in CPRD GOLD: Risk of Bleeding and Cardiovascular Outcomes From Anticoagulant Use.
Journal article
Hunt NB. et al, (2026), Clin Pharmacol Ther
Data Resource Profile: Prostate cancer data from Clinical Practice Research Datalink linked hospital records, mortality data and cancer registry standardized to the Observational Medical Outcomes Partnership common data model (CPRD-PCa-OMOP).
Journal article
Tan EH. et al, (2026), Int J Epidemiol, 55
Incidence and survival of head and neck cancers in the United Kingdom 2000-2021.
Journal article
Miquel-Dominguez A. et al, (2026), Cancer Epidemiol, 101